InterMune, Inc. - Financial and Strategic Analysis Review

Summary

InterMune, Inc. - Financial and Strategic Analysis Review

InterMune, Inc. (InterMune) is a biopharmaceutical company engaged in the development and marketing of innovative therapies in areas of pulmonology and hepatology. The company is developing a pipeline of pulmonology and hepatology products for treating idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. Its pulmonology products consist of a Phase 3 program, CAPACITY for treating patients with IPF and a research program on small molecules for pulmonary diseases. Its hepatology product is the HCV protease inhibitor compound ITMN-191 and a research program which evaluates new targets in hepatology. The company is headquartered in California, United States

Global Markets Direct's InterMune, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of InterMune, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • InterMune, Inc. - Key Facts
  • InterMune, Inc. - Business Description
  • InterMune, Inc. - Major Products and Services
  • InterMune, Inc. - History
  • InterMune, Inc. - SWOT Analysis
  • SWOT Analysis - Overview
  • InterMune, Inc. - Strengths
  • Strength - Sturdy Research and Development Activities
  • Strength - Agreement with Roche
  • InterMune, Inc. - Weaknesses
  • Weakness - History of Operating Losses
  • Weakness - Lack of Manufacturing Facility
  • Weakness - Reliance on a Single Supplier
  • InterMune, Inc. - Opportunities
  • Opportunity - Establishing Appropriate Alliances
  • Opportunity - Changing Demographics
  • Opportunity - Rising Healthcare Expenditure in the US
  • Opportunity - Biotech Focus
  • InterMune, Inc. - Threats
  • Threat - Delay in the Planned Clinical Trials
  • Threat - Product Liability Lawsuits
  • Threat - Usage of Hazardous Materials
  • Threat - Tightening of the FDA's Regulatory Oversight
  • Threat - Impact of Financial Crisis
  • Threat - Industry Consolidation
  • InterMune, Inc. - Key Competitors
  • InterMune, Inc. - Key Employees
  • InterMune, Inc. - Key Employee Biographies
  • InterMune, Inc. - Company Statement
  • InterMune, Inc. - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • InterMune, Inc. - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • InterMune, Inc., Key Facts
  • InterMune, Inc., Major Products and Services
  • InterMune, Inc., History
  • InterMune, Inc., Key Employees
  • InterMune, Inc., Key Employee Biographies
  • InterMune, Inc., Subsidiaries
  • InterMune, Inc., Ratios based on current share price
  • InterMune, Inc., Annual Ratios
  • InterMune, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • InterMune, Inc., Ratio Charts